Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Currently, no approved monoclonal antibody (mAb) therapies exist for human multiple myeloma (MM). Here we characterized cell surface CS1 as a novel MM antigen and further investigated the potential therapeutic utility of HuLuc63, a humanized anti-CS1 mAb, for treating human MM. CS1 mRNA and protein...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Tai, Yu-Tzu, Dillon, Myles, Song, Weihua, Leiba, Merav, Li, Xian-Feng, Burger, Peter, Lee, Alfred I., Podar, Klaus, Hideshima, Teru, Rice, Audie G., van Abbema, Anne, Jesaitis, Lynne, Caras, Ingrid, Law, Debbie, Weller, Edie, Xie, Wanling, Richardson, Paul, Munshi, Nikhil C., Mathiot, Claire, Avet-Loiseau, Hervé, Afar, Daniel E. H., Anderson, Kenneth C.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2008
נושאים:
Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515112/
https://ncbi.nlm.nih.gov/pubmed/17906076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-08-107292
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים